How to buy Memphasys shares | A$0.12

Memphasys Limited is a biotechnology business based in Australia. Memphasys shares (MEM) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $0.12 – a decrease of 11.11% over the previous week. and has a market cap (total outstanding shares value) of $90.6 million.

How to buy shares in Memphasys

1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
3. Search for Memphasys . Find the share by name or ticker symbol: MEM. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Memphasys reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At today's price of $0.12, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
6. Check in on your investment. Congratulations, you own a part of Memphasys . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

🧪How we chose these brokers

For our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.

How has coronavirus impacted Memphasys 's share price?

Since the stock market crash in March caused by coronavirus, Memphasys 's share price has had significant positive movement.

Its last market close was $0.12, which is 49.17% up on its pre-crash value of $0.061 and 263.64% up on the lowest point reached during the March crash when the shares fell as low as $0.033.

If you had bought $1,000 worth of Memphasys shares at the start of February 2020, those shares would have been worth $744.68 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $2,553.19.

Memphasys share price

Use our graph to track the performance of MEM stocks over time.

Memphasys shares at a glance

• Key figures

Information last updated 2020-10-21.

Latest market close	AUDA$0.12
52-week range	AUDA$0.033 - AUDA$0.155
50-day moving average	AUDA$0.1108
200-day moving average	AUDA$0.0857
Target price	N/A
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	AUDA$-0.003

Share Trading Account Offer

IG Share Trading Offer

AUD 8

Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

• Brokerage - AU shares: From AUD 5 or 0.05%
• Brokerage - US shares: USD 0
• Sign-up process: Instant
• Support - After hours: Yes

Go to site

More info

Important: Share trading carries risk of capital loss.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Memphasys stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Memphasys Limited by TradingView

Memphasys price performance over time

Historical closes compared with the close of A$0.12 on 2020-10-22

1 week (2020-10-16)	-11.11%
1 month (2020-09-23)	20.00%
3 months (2020-07-23)	9.09%
6 months (2020-04-23)	150.00%

1 year (2019-10-23)	48.15%
2 years (2018-10-23)	129.89%
3 years (2017-10-23)	306.78%
5 years (2015-10-23)	-64.99%

Memphasys financials

Gross profit TTM	$0
Return on assets TTM	-8.7%
Return on equity TTM	-14.33%
Profit margin	0%
Book value	0.013
Market capitalisation	$90.6 million

TTM: trailing 12 months

Memphasys share dividends

We're not expecting Memphasys to pay a dividend over the next 12 months.

Have Memphasys 's shares ever split?

Memphasys 's shares were split on a 1:15 basis on 15 August 2018. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Memphasys shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Memphasys shares which in turn could have impacted Memphasys 's share price.

Memphasys share price volatility

Over the last 12 months, Memphasys 's shares have ranged in value from as little as $0.033 up to $0.155. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Memphasys 's is 1.016. This would suggest that Memphasys 's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Memphasys overview

Memphasys Limited, a bio-separations company, develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. It primarily develops Felix that uses high quality sperm cells from semen samples for human assisted reproductive technologies for treating male factor infertility; hydrogels; and other polymer membranes to separate cells from fluids. The company was formerly known as NuSep Holdings Limited and changed its name to Memphasys Limited in July 2016. Memphasys Limited was incorporated in 2006 and is headquartered in Homebush, Australia.

Frequently asked questions

• What percentage of Memphasys is owned by insiders?

  Currently 73.854% of Memphasys shares are held by insiders.

• When does the fiscal year end for Memphasys ?

  Memphasys 's fiscal year ends in June.

• Where is Memphasys based?

  Memphasys 's address is: 30 Richmond Road, Homebush, NSW, Australia, 2140

• What is Memphasys 's ISIN number?

  Memphasys 's international securities identification number is: AU000000MEM5